Quantcast

Centerbridge in exclusive talks to buy Magellan Health


Shutterstock photo


June 26 (Reuters) - U.S. healthcare plan and pharmacy benefits manager Magellan Health Inc is in exclusive talks for a possible sale to private equity firm Centerbridge Partners LP, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

The companies could reach an agreement next month, and should the companies strike a deal, Centerbridge may sell Magellan's assets such as its pharmacy-benefit management business, according to the report

Shares of Magellan, which was valued at $1.6 billion Wednesday morning, rose as much as 7% on the report.






This article appears in: World Markets , Stocks , Technology
Referenced Symbols: MGLN



More from Reuters

Subscribe







See Reuters News













Research Brokers before you trade

Want to trade FX?